Bayer Proposes $7.25B Settlement in Roundup Cancer Lawsuits
The Spin
Establishment-critical narrative
Bayer's massive settlement proves Roundup poses serious cancer risks that the company deliberately concealed from consumers for decades. Juries have repeatedly sided with victims, awarding billions in damages because the evidence linking glyphosate to non-Hodgkin lymphoma is overwhelming. This $7.25 billion payout marks corporate accountability for poisoning Americans with a dangerous product.
Pro-establishment narrative
The EPA has thoroughly reviewed glyphosate and determined it's not carcinogenic to humans when used as directed, contradicting activist claims. Bayer is settling purely to end costly litigation uncertainty, not because Roundup is dangerous, and the company has won 13 of 24 jury verdicts. Federal regulators approve the product without cancer warnings because the science supports its safety.